Amplify Seymour Cannabis ETF (CNBS)
- Previous Close
4.3700 - Open
4.4300 - Bid 4.4900 x 1100
- Ask 4.5500 x 1000
- Day's Range
4.4300 - 4.5641 - 52 Week Range
3.7300 - 6.4800 - Volume
8,799 - Avg. Volume
20,700 - Net Assets 27.98M
- NAV 4.37
- PE Ratio (TTM) --
- Yield 0.00%
- YTD Daily Total Return 2.34%
- Beta (5Y Monthly) 1.33
- Expense Ratio (net) 0.75%
The fund will invest at least 80% of its net assets in the securities of companies that derive 50% or more of their revenue from the cannabis and hemp ecosystem and in derivatives that have economic characteristics similar to such securities. It is an actively managed ETF that seeks to provide investment exposure to global companies principally engaged in the emerging cannabis and hemp ecosystem across one of three classifications. The fund is non-diversified.
Amplify ETFs
Fund Family
Miscellaneous Sector
Fund Category
27.98M
Net Assets
2019-07-15
Inception Date
Performance Overview: CNBS
View MoreTrailing returns as of 11/1/2024. Category is Miscellaneous Sector.
People Also Watch
Holdings: CNBS
View MoreTop 6 Holdings (38.62% of Total Assets)
Sector Weightings
Related ETF News
View More
Research Reports: CNBS
View MoreWith Its Attractive Footprint, Green Thumb Should Benefit From Growing US Legal Market Demand
Green Thumb Industries is headquartered in Chicago, Illinois, and produces and sells medicinal and recreational cannabis through wholesale and retail channels in the United States. It has a presence in 14 states and operates 97 cannabis stores under the brand Rise. GTI is focusing its expansion on limited license states with large populations, and it does not currently export into the global medical market due to US federal prohibition. It offers multiple products under a portfolio of cannabis consumer packaged goods brands, including &Shine, Beboe, Dogwalkers, Doctor Solomon’s, Good Green, incredibles, and RYTHM.
RatingPrice TargetCuraleaf Offers Unique Investment Exposure to Both International Medical and American Cannabis
Curaleaf is headquartered in Wakefield, Massachusetts, and cultivates and sells medicinal and recreational cannabis in the US. The company has operations in 17 states. Its brands include Curaleaf, Select, and Grassroots. The company has made acquisitions that give it exposure to the growing European market, a unique feature among US multistate operators.
RatingPrice TargetGreen Thumb's Growth Should Benefit From Easing Federal Prohibition and New State Legalizations
Green Thumb Industries is headquartered in Chicago, Illinois, and produces and sells medicinal and recreational cannabis through wholesale and retail channels in the United States. It has a presence in 14 states and operates 92 cannabis stores under the brand Rise. GTI is focusing its expansion on limited license states with large populations, and it does not currently export into the global medical market due to US federal prohibition. It offers multiple products under a portfolio of cannabis consumer packaged goods brands, including &Shine, Beboe, Dogwalkers, Doctor Solomon’s, Good Green, incredibles, and RYTHM.
RatingPrice TargetFirst Pillar of Germany's Cannabis Legalization Begins April 1; Legal Sales to Come Later
Curaleaf is headquartered in Wakefield, Massachusetts, and cultivates and sells medicinal and recreational cannabis in the U.S. The company has operations in 18 states. Its brands include Curaleaf, UKU, Select, and Grassroots. The company acquired EMMAC Life Sciences in March 2021, beginning its foray into the global medical market in competition with Canadian cannabis producers.
RatingPrice Target